Lack of A563G (1188V) Hissense mutation in RIZ/PRDM2 in human diffuse large B-cell lymphomas

Genes Chromosomes and Cancer

Volumn 46, Issue 4, 2007, Pages 416-418

  Tam, Wayne ^a   Gomez, Mario F ^a   Chadburn, Amy ^a   Knowles, Daniel M ^a   Houldsworth, Jane ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; ISOLEUCINE; MUTANT PROTEIN; TUMOR SUPPRESSOR PROTEIN; VALINE; DNA BINDING PROTEIN; HISTONE LYSINE METHYLTRANSFERASE; NUCLEAR PROTEIN; PRDM2 PROTEIN, HUMAN; PRDM2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; B CELL LYMPHOMA; CANCER INHIBITION; CARCINOGENESIS; CHROMOSOME BANDING PATTERN; CHROMOSOME DELETION 13; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC SCREENING; HUMAN; LARGE CELL LYMPHOMA; LETTER; MISSENSE MUTATION; MUTATIONAL ANALYSIS; PRDM2 GENE; PRIORITY JOURNAL; PROTEIN DOMAIN; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; ANIMAL; GENETICS; MOUSE; MOUSE MUTANT;

AMINO ACID SUBSTITUTION; ANIMALS; DNA-BINDING PROTEINS; HISTONE-LYSINE N-METHYLTRANSFERASE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MICE; MICE, KNOCKOUT; MUTATION, MISSENSE; NUCLEAR PROTEINS; TRANSCRIPTION FACTORS;

EID: 33947143389     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20409     Document Type: Letter

References (8)

1. Canote R, Du Y, Carling T, Tian F, Peng Z, Huang S. 2002. The tumor suppressor gene RIZ in cancer gene therapy. Oncol Rep 9:57-60.
2. Chen W, Houldsworth J, Olshen AB, Nanjangud G, Chaganti S, Venkatraman ES, Halaas J, Teruya-Feldstein J, Zelenetz AD, Chaganti RS. 2006. Array comparative genomic hybridization reveals genomic copy number changes associated with outcome in diffuse large B-cell lymphomas. Blood 107:2477-2285.
3. Cigudosa JC, Parsa NZ, Louie DC, Filippa DA, Jhanwar SC, Johansson B, Mitelman F, Chaganti RS. 1999. Cytogenetic analysis of 363 consecutively ascertained diffuse large B-cell lymphomas. Genes Chromosomes Cancer 25:123-133.
4. Fan X, Furnari FB, Cavenee WK, Castresana JS. 2001. Non-isotopic silver-stained SSCP is more sensitive than automated direct sequencing for the detection of PTEN mutations in a mixture of DNA extracted from normal and tumor cells. Int J Oncol 18:1023-1026.
5. Kim KC, Geng L, Huang S. 2003. Inactivation of a histone methyltransferase by mutations in human cancers. Cancer Res 63:7619-7623.
6. Pasqualucci L, Compagno M, Houldsworth J, Monti S, Grunn A, Nandula SV, Aster JC, Murty W, Shipp MA, Dalla-Favera R. 2006. Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma. J Exp Med 203:311-317.
7. Steele-Perkins G, Fang W. Yang XH, Van Gele M, Carling T, Gu J, Buyse IM, Fletcher JA, Liu J, Bronson R, Chadwick RB, de la Chapelle A, Zhang X, Speleman F, Huang S. 2001. Tumor formation and inactivation of RIZ1, an Rb-binding member of a nuclear protein-methyltransferase superfamily. Genes Dev 15:2250-2262.
8. Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM. 2006. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood 107: 4090-4100.